Rani Therapeutics Holdings, Inc.RANINASDAQ

Revenue (LTM)

$1M

Net Income (LTM)

$-30M

+11.6% YoY

Free Cash Flow

$-36M

Revenue CAGR (5Y)

+22.1%

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	3↑488.1%	0	0	1
Gross Profit	0	3↑488.1%	0	-1	1↑225.1%
Operating Income	-17	-52↓211.9%	-63↓23.0%	-66↓4.2%	-53↑19.3%
Net Income	-17	-8↑50.1%	-31↓267.2%	-34↓11.1%	-30↑11.6%
EBITDA	-16	-52↓226.4%	-62↓18.4%	-65↓5.9%	-51↑22.6%
EPS Diluted	-0.85	-0.42↑50.6%	-1.28↓204.8%	-1.33↓3.9%	-1.05↑21.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	73	117↑60.8%	27↓77.0%	6↓78.3%	4↓35.8%
Total Current Assets	75	120↑59.6%	101↓15.6%	51↓49.6%	30↓41.5%
Total Assets	79	124↑56.4%	108↓13.0%	58↓46.4%	37↓36.7%
Total Current Liabilities	5	3↓50.3%	5↑82.4%	8↑65.9%	20↑149.0%
Total Liabilities	193	3↓98.6%	34↑1188.7%	32↓4.6%	33↑2.1%
Total Equity	-113	47↑141.8%	37↓22.3%	13↓65.1%	2↓84.5%
Total Debt	4	0	30	30↓0.4%	30↓1.3%
Net Debt	-69	-117↓69.5%	3↑102.7%	24↑655.7%	26↑7.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-15	-32↓115.5%	-47↓44.3%	-51↓10.1%	-35↑30.7%
Capital Expenditure	-1	-1↑57.8%	-2↓220.0%	-1↑24.1%	-0↑78.2%
Free Cash Flow	-16	-33↓102.7%	-48↓47.0%	-52↓9.0%	-36↑31.8%
Stock-Based Comp	0	23	16↓30.2%	19↑20.4%	16↓15.7%
Net Change in Cash	57	44↓21.5%	-90↓302.6%	-21↑76.5%	-2↑90.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance